Intelligent Application of Breast Cancer Trials Data in the Clinic
This meeting commenced with a talk from Prof Loibl on neoadjuvant and adjuvant strategies for HER2positive (human epidermal growth factor receptor 2-positive) early breast cancer (EBC), which featured a précis on the most pertinent, recent trial data and how these data may shape future treatment dec...
Main Authors: | Joanne Frankli, Sunil Verma, Sibylle Loibl, Pierfranco Conte, Peter Schmid, Christos Sotiriou |
---|---|
Format: | Article |
Language: | English |
Published: |
European Medical Journal
2015-11-01
|
Series: | European Medical Journal Oncology |
Subjects: | |
Online Access: | http://emjreviews.com/wp-content/uploads/Intelligent-Application-of-Breast-Cancer-Trials-Data-in-the-Clinic.pdf |
Similar Items
-
Cabozantinib Versus Everolimus in Patients with Advanced Renal Cell Carcinoma: Results of a Randomised Phase III Trial (METEOR)
by: Toni Choueiri
Published: (2015-11-01) -
Incorporating PARP Inhibition in Cancer Therapy: Key Questions, Expert Answers
by: Tristin Abair, et al.
Published: (2015-11-01) -
Navigating the mCRPC Landscape: Exploring Key Clinical Decision Points
by: Fred Saad, et al.
Published: (2015-05-01) -
International Evidence on Effective Early Childhood Care and Education Programs: A Review of Best Practices
by: Giselle Emilia Navarro-Cruz, et al.
Published: (2018-07-01) -
Evidence-based treatment planning in mCRC- The key to maximising outcomes
by: Dirk Arnold, et al.
Published: (2013-10-01)